Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Anebulo Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Anebulo Pharmaceuticals Inc market cap is $28,549.00.
What is the 52-week high for Anebulo Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anebulo Pharmaceuticals Inc 52 week high is $2.78 as of October 20, 2026.
What is the 52-week low for Anebulo Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anebulo Pharmaceuticals Inc 52 week low is $0.0004 as of October 20, 2026.
What is Anebulo Pharmaceuticals Inc stock price today?
Anebulo Pharmaceuticals Inc stock price today is $0.295.
What was Anebulo Pharmaceuticals Inc stock price yesterday?
Anebulo Pharmaceuticals Inc stock price yesterday was $0.0007.
What is the Price-to-Book ratio of Anebulo Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Anebulo Pharmaceuticals Inc P/B ratio is 0.0036.
What is the 50-day moving average of Anebulo Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Anebulo Pharmaceuticals Inc 50-day moving average is $0.3155.